Both in Pharmaceuticals
Amylyx Pharmaceuticals vs Acadia Pharmaceuticals
Over the past year AMLX returned +105.5% and ACAD returned −9.1%; their daily moves had a correlation of 0.32.
AMLX +105.5% ACAD −9.1%Growth of $1, one year, split-adjusted
| Metric | AMLX | ACAD |
|---|---|---|
| Price | $27.95 | $20.34 |
| Market cap | $3.51B | $3.50B |
| Today | −3.15% | −1.24% |
| 1 month | +0.6% | +1.9% |
| 6 months | +69.8% | −8.4% |
| Year to date | +131.4% | −23.9% |
| 1 year | +98.9% | −10.6% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.2× |
| Price / sales | — | 3.1× |
| Net cash | $250.8M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 112.3% | 43.8% |
| Short % of float | 13.7% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).